{"AlternateComparison":true,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
Avitene™ Avitene™ Ultrafoam™ Collagen Sponge

Avitene™ Ultrafoam™ Collagen Sponge, 100/Thin sq cm

Icon to close the modal
지원
Becton, Dickinson and Company
전화 아이콘
(82.2) 080-340-3800
bd_korea@bd.com
모달 닫기 아이콘
감사 모달 닫기 아이콘
영업팀에 연락해 주셔서 감사합니다!
영업 담당자가 곧 연락을 드립니다.
Address
위치 아이콘
Becton Dickinson Korea Co., Ltd. 한국 서울특별시 강남구 테헤란로 142 아크플레이스 16층 06236
Overview

지혈에 대해 검증된 솔루션으로 표준화하십시오.

Avitene™ 미세원섬유 콜라겐 기반 지혈제는 혈전 형성을 가속화하는 것으로 입증된 활성 흡수성 콜라겐 지혈제입니다. Avitene™은 혈소판 응집과 단백질 방출을 효과적으로 촉진해 섬유소를 형성하여 지혈합니다.

true
Features and Benefits
Promotional Story
false
Specification

GTIN - Case

10801741010559

6

GTIN - Each

00801741010552

1


Quantity

6/cs.


Dimensions

100/Thin 8cm x 12.5cm x 3mm (3 1/8" x 5" x 1/8")

GTIN

GTIN - Case 10801741010559 6
GTIN - Each 00801741010552 1

Packaging

Quantity 6/cs.

Product Basic Specification

Dimensions 100/Thin 8cm x 12.5cm x 3mm (3 1/8" x 5" x 1/8")
Electronic Instructions for Use (eIFUs)
Resources
Frequently Asked Questions
false
Alternatives Comparison
  • Alternatives Comparison

    • Product Name
    • SKU Number
    • Dimensions
    • Quantity
    • Product Name
    • SKU Number
    • Dimensions
    • Quantity
    • Product Name
    • SKU Number
    • Dimensions
    • Quantity
    • Product Name
    • SKU Number
    • Dimensions
    • Quantity
    • Product Name
    • SKU Number
    • Dimensions
    • Quantity
  • Product Image
    • Product Name

      Avitene™ Ultrafoam™ Collagen Sponge, 100/Thin sq cm
    • SKU Number

      1050050
    • Dimensions

      100/Thin 8cm x 12.5cm x 3mm (3 1/8" x 5" x 1/8")
    • Quantity

      6/cs.
  • Product Image
    • Product Name

      Avitene™ Ultrafoam™ Collagen Sponge, 100 sq cm
    • SKU Number

      1050040
    • Dimensions

      100 sq cm 8cm x 12.5cm x 1cm (3 1/8" x 5" x 3/8")
    • Quantity

      6/cs.
Related Products
RELATED PRODUCTS NOT AVAILABLE
References

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

Animal data may not correlate to outcomes in humans. Data on file.

Indications

Avitene™ Microfibrillar Collagen Hemostat (MCH) and Avitene™ UltraFoam™ sponge are indicated in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

Contraindications

•Avitene™ MCH and Avitene™ UltraFoam™ sponge should not be used in the closure of skin incisions as they may interfere with the healing of the skin edges. This is due to simple mechanical interposition of dry collagen and not to any intrinsic interference with wound healing.

•It has been reported with other collagen hemostatic agents, that by filling porosities of cancellous bone, they may significantly reduce the bond strength of methylmethacrylate adhesives. Avitene™ MCH and Avitene™ UltraFoam™ sponge should not, therefore, be employed on bone surfaces to which prosthetic materials are to be attached with methylmethacrylate adhesives.

 

Warnings

•Avitene™ MCH and Avitene™ UltraFoam™ are inactivated by autoclaving. Ethylene oxide reacts with bound hydrochloric acid to form ethylene chlorohydrin. These devices have been designed for single use only. Reuse, reprocessing, resterilization or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the devices and may lead to device failure which may result in injury to the patient. Reuse, reprocessing, resterilization or repackaging may also create a risk of contamination of the device and/or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another. Contamination of the devices may lead to injury, illness or death of the patient or end user. Opened, unused product should be discarded. Moistening Avitene™ MCH or wetting with saline or thrombin impairs its hemostatic efficacy. It should be used dry.

•As with any foreign substance, use of Avitene™ MCH and Avitene™ UltraFoam™ in contaminated wounds may enhance infection.

•Avitene™ UltraFoam™ sponge should not be used in instances of pumping arterial hemorrhage.

•Avitene™ UltraFoam™ should not be used where blood or other fluids have pooled, or in cases where the point of hemorrhage is submerged as it may mask an underlying source of bleeding, resulting in hematoma.

•Avitene™ UltraFoam™ sponge will not act as a tampon or plug in a bleeding site, nor will it close off an area of blood collecting behind a tampon.

•Avitene™ UltraFoam™ sponge is not intended to treat systemic coagulation disorders. Avitene™ MCH and Avitene™ UltraFoam™ are not for injection, intraocular or intravascular use.

 

Adverse Reactions

•The most serious adverse reaction reported which may be related to the use of Avitene™ MCH or other collagen products are potentiation of infection including abscess formation, hematoma, wound dehiscence and mediastinitis.

•Other reported adverse reactions possibly related are adhesion formation, allergic reaction, foreign body reaction and subgaleal seroma (report of a single case) and increased incidence of alveolalgia when used for packing of dental extraction sockets.

•Transient laryngospasm due to aspiration of dry material has been reported following use of Avitene™ MCH in tonsillectomy.

Please consult package insert for more detailed safety information and instructions for use.

References

See full Instructions for Use for detailed application instructions.

true
true